Adjuvant chemotherapy cancer therapy anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Tumor Cells, Cultured Lymph Nodes HCT116 Cells Axilla Neoplastic Stem Cells MCF-7 Cells

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases55

Breast Neoplasms Neoplasms Neoplasm Recurrence, Local Lung Neoplasms Colonic Neoplasms Radiation Injuries Adenocarcinoma Lymphatic Metastasis Neoplasm Metastasis Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Ovarian Neoplasms Pancreatic Neoplasms Carcinoma Rectal Neoplasms Neoplasm Invasiveness Carcinoma, Squamous Cell Brain Neoplasms Sarcoma Prostatic Neoplasms Bone Neoplasms Urinary Bladder Neoplasms Liver Neoplasms Disease Progression Osteosarcoma Testicular Neoplasms Head and Neck Neoplasms Neoplasms, Second Primary Neoplasms, Radiation-Induced Recurrence Neutropenia Nasopharyngeal Neoplasms Amenorrhea Soft Tissue Neoplasms Neoplasms, Experimental Neoplasms, Germ Cell and Embryonal Radiation Pneumonitis Neovascularization, Pathologic Neoplasms, Hormone-Dependent Esophageal Neoplasms Peritoneal Neoplasms Glioblastoma Radiation Injuries, Experimental Uterine Cervical Neoplasms Fatigue Carcinoma, Transitional Cell Carcinoma, Lobular Melanoma Vomiting Glioma Endometrial Neoplasms Cell Transformation, Neoplastic Nausea Germinoma

Chemicals and Drugs72

Antineoplastic Agents Cisplatin Doxorubicin Fluorouracil Cyclophosphamide Adjuvants, Immunologic Methotrexate Antimetabolites, Antineoplastic Paclitaxel Adjuvants, Pharmaceutic Tegafur Epirubicin Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Anthracyclines Taxoids Etoposide Tamoxifen Tumor Markers, Biological Vinblastine Levamisole Freund's Adjuvant Organoplatinum Compounds Carboplatin Receptors, Estrogen Receptor, erbB-2 Deoxycytidine Antineoplastic Agents, Hormonal Antineoplastic Agents, Alkylating Camptothecin Tumor Suppressor Protein p53 Mitomycin Leucovorin Bleomycin Neoplasm Proteins Lomustine Drug Carriers Uracil Receptors, Progesterone Oxonic Acid Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Radiation-Sensitizing Agents Cancer Vaccines Vincristine RNA, Messenger Thiotepa Ifosfamide Mitoxantrone RNA, Small Interfering Semustine DNA, Neoplasm Dacarbazine Bridged Compounds Platinum Compounds Antigens, Neoplasm P-Glycoprotein Floxuridine Thymidylate Synthase Enzyme Inhibitors Receptor, Epidermal Growth Factor DNA-Binding Proteins Daunorubicin Platinum DNA Topoisomerases, Type II Proto-Oncogene Proteins c-bcl-2 Protein Kinase Inhibitors Melphalan Carmustine Granulocyte Colony-Stimulating Factor Drug Combinations Ki-67 Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Neoplasm Staging Disease-Free Survival Treatment Outcome Radiotherapy, Adjuvant Prognosis Survival Analysis Survival Rate Radiation Dosage Drug Administration Schedule Neoadjuvant Therapy Follow-Up Studies Drug Screening Assays, Antitumor Dose-Response Relationship, Radiation Clinical Trials as Topic Radiotherapy Mastectomy Retrospective Studies Kaplan-Meier Estimate Xenograft Model Antitumor Assays Drug Delivery Systems Prospective Studies Radiotherapy Dosage Radiation Monitoring Multivariate Analysis Randomized Controlled Trials as Topic Gastrectomy Molecular Targeted Therapy Cystectomy Pneumonectomy Risk Factors Drug Carriers Early Detection of Cancer Neoplasm Transplantation Immunohistochemistry Lymph Node Excision Proportional Hazards Models Clinical Trials, Phase III as Topic Risk Assessment Chemoradiotherapy Predictive Value of Tests SEER Program Antineoplastic Protocols Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Administration, Oral Tumor Burden Blotting, Western Mastectomy, Segmental Transplantation, Heterologous Chemoradiotherapy, Adjuvant Immunotherapy Feasibility Studies Drug Design Infusions, Intravenous Models, Biological Actuarial Analysis Cohort Studies Tomography, X-Ray Computed Neoplasms, Experimental Inhibitory Concentration 50 Palliative Care Mastectomy, Radical Flow Cytometry Registries Hyperthermia, Induced Radiation Injuries, Experimental Mastectomy, Modified Radical Salvage Therapy Patient Selection Odds Ratio Cranial Irradiation Risk Drug Therapy Drug Evaluation, Preclinical Transfection Random Allocation Sensitivity and Specificity Radiometry Induction Chemotherapy

Phenomena and Processes31

Radiation Dosage Radiation, Ionizing Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Radiation Tolerance Apoptosis Time Factors Radiation Gene Expression Regulation, Neoplastic Cell Survival Dose-Response Relationship, Drug Cell Proliferation Premenopause DNA Damage Cell Cycle Menopause Drug Synergism Signal Transduction Mutation Gamma Rays Drug Resistance, Multiple DNA Repair Cell Division Inhibitory Concentration 50 Cosmic Radiation Odds Ratio Risk Down-Regulation Transfection Sensitivity and Specificity Ultraviolet Rays

Disciplines and Occupations5

Medical Oncology Radiation Oncology Immunohistochemistry Drug Design Nanomedicine

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Technology, Industry, Agriculture2

Nanoparticles Nanomedicine

Humanities1

Quality of Life

Information Science3

Survival Rate SEER Program Registries

Named Groups1

Health Care38

Disease-Free Survival Treatment Outcome Survival Analysis Survival Rate Radiation Dosage Radiation Injuries Follow-Up Studies Dose-Response Relationship, Radiation Clinical Trials as Topic Retrospective Studies Kaplan-Meier Estimate Prospective Studies Radiation Protection Radiation Monitoring Multivariate Analysis Randomized Controlled Trials as Topic Age Factors Risk Factors Proportional Hazards Models Clinical Trials, Phase III as Topic Risk Assessment Predictive Value of Tests SEER Program Antineoplastic Protocols Feasibility Studies Actuarial Analysis Cohort Studies Palliative Care Cosmic Radiation Registries Radiation Injuries, Experimental Patient Selection Odds Ratio Risk National Cancer Institute (U.S.)Random Allocation Sensitivity and Specificity Ultraviolet Rays

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Breast Neoplasms Combined Modality Therapy Neoplasm Staging Cisplatin Doxorubicin Neoplasms Fluorouracil Disease-Free Survival Cyclophosphamide Treatment Outcome Adjuvants, Immunologic Radiotherapy, Adjuvant Prognosis Survival Analysis Neoplasm Recurrence, Local Survival Rate Cell Line, Tumor Radiation Dosage Radiation, Ionizing Lung Neoplasms Colonic Neoplasms Methotrexate Radiation Injuries Drug Resistance, Neoplasm Antimetabolites, Antineoplastic Paclitaxel Drug Administration Schedule Neoadjuvant Therapy Follow-Up Studies Drug Screening Assays, Antitumor Adenocarcinoma Adjuvants, Pharmaceutic Tegafur Dose-Response Relationship, Radiation Lymphatic Metastasis Epirubicin Radiation Tolerance Antineoplastic Agents, Phytogenic Neoplasm Metastasis Stomach Neoplasms Antibiotics, Antineoplastic Clinical Trials as Topic Anthracyclines Apoptosis Carcinoma, Non-Small-Cell Lung Radiotherapy Colorectal Neoplasms Ovarian Neoplasms Taxoids Etoposide Tamoxifen Mice, Nude Time Factors Tumor Markers, Biological Mastectomy Retrospective Studies Radiation Vinblastine Levamisole Kaplan-Meier Estimate Freund's Adjuvant Gene Expression Regulation, Neoplastic Organoplatinum Compounds Carboplatin Cell Survival Xenograft Model Antitumor Assays Drug Delivery Systems Pancreatic Neoplasms Receptors, Estrogen Receptor, erbB-2 Prospective Studies Dose-Response Relationship, Drug Deoxycytidine Antineoplastic Agents, Hormonal Carcinoma Radiotherapy Dosage Antineoplastic Agents, Alkylating Radiation Protection Tumor Cells, Cultured Rectal Neoplasms Neoplasm Invasiveness Radiation Monitoring Medical Oncology Cell Proliferation Multivariate Analysis Camptothecin Randomized Controlled Trials as Topic Tumor Suppressor Protein p53 Carcinoma, Squamous Cell Brain Neoplasms Mitomycin Sarcoma Leucovorin Prostatic Neoplasms Bone Neoplasms Bleomycin Gastrectomy

No FAQ available that match "adjuvant chemotherapy cancer therapy anticancer drugs or radiation"